Health Care & Life Sciences » Pharmaceuticals | Hutchison China MediTech Ltd.

Hutchison China MediTech Ltd. | Cash Flow

Fiscal year is January-December. All values GBP Thousands.
2013
2014
2015
2016
2017
2018
Net Income before Extraordinaries
4,505.20
2,481.50
6,824.80
10,788.60
17,830.90
53,461.60
Depreciation, Depletion & Amortization
616.10
745.80
1,294.70
1,709.00
2,001.80
2,692.40
Other Funds
369.10
716.00
1,250.80
418.00
1,237.70
20,763.40
Funds from Operations
6,000.90
24.30
328.60
9,634.60
4,318.90
30,005.90
Changes in Working Capital
2,784.20
5,100.90
6,471.40
2,542.80
11,263.20
10,313.50
Net Operating Cash Flow
3,216.70
5,076.70
6,142.80
7,091.80
6,944.30
19,692.50
Capital Expenditures
1,599.40
2,264.70
2,175.70
3,206.80
3,897.30
Sale of Fixed Assets & Businesses
-
2,276.30
-
-
-
Purchase/Sale of Investments
-
7,396.60
7,971.60
21,692.70
198,599.60
Net Investing Cash Flow
1,599.40
7,385.10
5,795.90
24,899.60
202,496.90
Issuance/Reduction of Debt, Net
8,760.20
3,232.20
2,097.80
3,021.60
13,159.40
Net Financing Cash Flow
8,395.50
2,247.10
3,581.00
68,505.90
212,138.00
Net Change in Cash
10,297.50
4,808.20
4,585.00
35,196.00
4,530.10
Free Cash Flow
1,617.30
2,811.90
8,318.50
10,298.70
10,841.60
Change in Capital Stock
4.50
1,701.10
232.40
71,945.50
226,535.20
Exchange Rate Effect
284.70
252.60
657.20
1,318.50
1,833.30

About Hutchison China MediTech

View Profile
Address
Cheung Kong Center
Hong Kong
Hong Kong
Employees -
Website http://www.chi-med.com
Updated 07/08/2019
Hutchison China MediTech Ltd. is a holding company, which engages in the research and development, manufactures, and sells pharmaceuticals and health oriented consumer products. It operates through the Innovation Platform and Commercial Platform segments. The Innovation Platform segment relates to research and development of innovative therapeutics in oncology and autoimmune diseases.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.